AzTrials
AzTrials

TracheostomyDekanNCT06047665

Outcomes After Tracheal Cannula Removal

An observational study of Tracheostomy, run by Katharina Winiker at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This longitudinal observational study involves an integrated knowledge translation (IKT) approach involving key stakeholders in the project team to evaluate the tracheostomy management in patients hospitalized in the Swiss Paraplegic Centre Nottwil (SPC). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Tracheostomy
How many people
150 participants
Where
1 siteSwitzerland
Study dates
25 Aug 2023to Aug 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Tracheotomized patients hospitalized in the Swiss Paraplegic Centre Nottwil.

Who may be able to join

  • at the time of recruitment, tracheotomized adult in-patients (≥ 18 years) of the SPC with any medical diagnosis
  • decannulated in the Swiss Paraplegic Center Nottwil within the project's data collection period
  • German, French, Italian or English as communication language
  • study consent

Who cannot join

  • patients for whom no decannulation is sought (e.g., due to degenerative illness)
  • patients for whom decannulation is planned in a clinic other than the SPC (e.g., patients hospitalized in the SPC for weaning only)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Gabi Müller Verbiest, PhD contact

41 939 55 63 ext. 0041

gabi.mueller@paraplegie.ch

Switzerland1 site, 1 recruiting
  • Swiss Paraplegic Center Nottwil

    Nottwil, Canton of Lucerne, 6207

    Gabi Müller, PhD, 41 939 55 63 ext. 0014, gabi.mueller@paraplegie.ch

    Sarah Stierli, BA, 41 939 58 92 ext. 0041, sarah.stierli@paraplegie.ch

    Recruiting

Other trials in Switzerland

About this study

Official title: Tracheostomy Decannulation Outcomes: A Longitudinal Observational Study

This longitudinal observational study involves an integrated knowledge translation (IKT) approach involving key stakeholders in the project team to evaluate the tracheostomy management in patients hospitalized in the Swiss Paraplegic Centre Nottwil (SPC).

Read the detailed description

Primary objective

  • to evaluate the rate of physical complications (that require treatment, intubation, recannulation or lead to death) in patients hospitalized in the SPC over three months following the removal of the tracheal cannula (decannulation).

Secondary objectives

  • to describe types of complications short-term (up to 4 days) and long-term (up to three months) post-decannulation
  • to assess predictors for short- and long-term complications post-decannulation
  • to explore patients' perspectives on decannulation outcomes
  • to evaluate individual trajectories of the clinical decannulation protocol
Conditions
Tracheostomy
Keywords
Tracheostomy, Decannulation, Complications

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. rate of physical complications post-decannulation

    Measured: for 3 months post-decannulation (assessment time points: 4 days, 1 month, and 3 months post-decannulation)

  2. rate of reintubation post-decannulation

    Measured: for 3 months post-decannulation (assessment time points: 4 days, 1 month, and 3 months post-decannulation)

  3. rate of recannulation post-decannulation

    Measured: for 3 months post-decannulation (assessment time points: 4 days, 1 month, and 3 months post-decannulation)

  4. rate of death post-decannulation

    Measured: for 3 months post-decannulation (assessment time points: 4 days, 1 month, and 3 months post-decannulation)

Secondary outcomes (3)
  1. types of decannulation-related physical complications short- and long-term

    including excessive secretion, altered respiratory frequency, respiratory insufficiency, respiratory infections, newly occuring neurological symptoms, sleep apnea, intratracheal complications, complications with tracheostoma

    Measured: for 3 months post-decannulation (assessment time points: 4 days, 1 month, and 3 months post-decannulation)

  2. candidate prognostic factors for physical complications post-decannulation

    individual demographic and clinical patient characteristics

    Measured: 1 week pre-decannulation, (4 days for one select parameter), 1 month, and 3 months post-decannulation

  3. patients' perspectives on decannulation outcomes

    A questionnaire will be used to assess advantages and disadvantages of the decannulation (8 questions, per question 3 - 6 pre-formulated answers to choose from). Additional, the Harvard Human Flourishing Measure (12 questions, rating from 0 to 10 per question, sum score to calculate the 'flourish measure') will be used.

    Measured: Questionnaire: 4 days, 1 month, and 3 months post-decannulation; Human Flourishing Measure: 1 week pre-decannulation and 3 months post-decannulation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2023
  2. Study start25 Aug 2023
  3. Primary completionAug 2026 (estimated)
  4. Study completionAug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06047665
Sponsor's protocol ID
2022-08
Acronym
Dekan
Status last verified
May 2025
First submitted
30 Aug 2023
Last updated
30 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Winiker K, Stierli S, Brinkhof MWG, Hamzic S, Schwegler H, Mueller G. Outcomes of Tracheostomy Decannulation: Study Protocol for a Longitudinal Observational Study. Int J Lang Commun Disord. 2026 Jan-Feb;61(1):e70165. doi: 10.1111/1460-6984.70165.

    PubMed 41355759

Questions about this trial

What is this clinical trial studying?

An observational study of Tracheostomy, run by Katharina Winiker at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gabi Müller Verbiest, PhD (41 939 55 63 ext. 0041, gabi.mueller@paraplegie.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

rate of physical complications post-decannulation (time frame: for 3 months post-decannulation (assessment time points: 4 days, 1 month, and 3 months post-decannulation)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06047665, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2026; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in